Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 447 publications

Clinical characteristics, cerebellar MR spectroscopy and response to 3,4-diaminopyridine in spinocerebellar ataxia 27B: the Sheffield Ataxia Centre experience.

Clinical characteristics, cerebellar MR spectroscopy and response to 3,4-diaminopyridine in spinocerebellar ataxia 27B: the Sheffield Ataxia Centre experience.

Journal: Journal of neurology
Published: August 11, 2025

Lambert Eaton Myasthenic Syndrome.

Lambert Eaton Myasthenic Syndrome.

Journal: International review of neurobiology
Published: July 17, 2025

Epidemiological analysis of Lambert-Eaton myasthenic syndrome in Türkiye: insights from a nationwide electronic health database.

Epidemiological analysis of Lambert-Eaton myasthenic syndrome in Türkiye: insights from a nationwide electronic health database.

Journal: Frontiers in neurology
Published: July 16, 2025

The recognition, physiology, and treatment of Lambert-Eaton myasthenic syndrome.

The recognition, physiology, and treatment of Lambert-Eaton myasthenic syndrome.

Journal: Disease-a-month : DM
Published: June 21, 2025

Long-term Efficacy and Safety of Amifampridine Phosphate (Firdapse®) in Japanese Patients with Lambert-Eaton Myasthenic Syndrome (LMS-005 Study).

Long-term Efficacy and Safety of Amifampridine Phosphate (Firdapse®) in Japanese Patients with Lambert-Eaton Myasthenic Syndrome (LMS-005 Study).

Journal: Internal medicine (Tokyo, Japan)
Published: June 18, 2025

The impact of experimental variables in twitch tension recording on triphasic action of phospholipase A2 neurotoxins at the neuromuscular junction and acetylcholine release.

The impact of experimental variables in twitch tension recording on triphasic action of phospholipase A2 neurotoxins at the neuromuscular junction and acetylcholine release.

Journal: Toxicon : official journal of the International Society on Toxinology
Published: June 05, 2025

Combined treatment with antitoxin and 3,4-diaminopyridine improves survival outcomes after lethal botulinum neurotoxin challenge.

Combined treatment with antitoxin and 3,4-diaminopyridine improves survival outcomes after lethal botulinum neurotoxin challenge.

Journal: Molecular medicine (Cambridge, Mass.)
Published: May 04, 2025

Congenital Myasthenic Syndrome With Adult Onset Due to the Novel Heterozygous c.1399_1404del Variant in the Downstream of Tyrosine Kinase-7 (DOK7): A Case Report.

Congenital Myasthenic Syndrome With Adult Onset Due to the Novel Heterozygous c.1399_1404del Variant in the Downstream of Tyrosine Kinase-7 (DOK7): A Case Report.

Journal: Cureus
Published: April 03, 2025

Slow-Channel Congenital Myasthenic Syndrome Due to the Novel Variant c.1396G_A in CHRNA1 That Responds Favorably to 3,4-Diaminopyridine: A Case Report.

Slow-Channel Congenital Myasthenic Syndrome Due to the Novel Variant c.1396G_A in CHRNA1 That Responds Favorably to 3,4-Diaminopyridine: A Case Report.

Journal: Cureus
Published: November 13, 2024

Mycobacterium abscessus Pulmonary Disease in a Myasthenia Gravis Patient: A Case Report.

Mycobacterium abscessus Pulmonary Disease in a Myasthenia Gravis Patient: A Case Report.

Journal: Respirology case reports
Published: November 06, 2024

A Unique Case of Non-paraneoplastic Lambert-Eaton Myasthenic Syndrome Treated With Subcutaneous Immunoglobulin: A Case Report and Review of Literature.

A Unique Case of Non-paraneoplastic Lambert-Eaton Myasthenic Syndrome Treated With Subcutaneous Immunoglobulin: A Case Report and Review of Literature.

Journal: Cureus
Published: May 21, 2024

Foodborne botulism outbreak with potential new management options.

Foodborne botulism outbreak with potential new management options.

Journal: Saudi medical journal
Published: May 15, 2024
Showing 1-12 of 447

Last Updated: 10/31/2025